NCT05941520 |
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer |
NCT05107674 |
A Study of NX-1607 in Adults With Advanced Malignancies |
NCT05691465 |
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells |
NCT06488365 |
In Vivo Liquid Biopsy of Melanoma (Cytophone) |
NCT06904365 |
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women |
NCT06465966 |
UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in Pencil-Beam Scanning |
NCT04812366 |
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer |
NCT06378866 |
Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial |
NCT02207465 |
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer |
NCT04329065 |
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer |
NCT06376565 |
Improving Colonoscopy Surveillance for Patients with High Risk Colon Polyps |
NCT06090266 |
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents |
NCT05693766 |
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort |
NCT05327465 |
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy |
NCT05800665 |
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer |
NCT05579366 |
Rinatabart Sesutecan (Rina-S) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) |
NCT06833866 |
Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer |
NCT05325866 |
A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression |
NCT05696626 |
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation |
NCT00899626 |
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples from Colorectal Cancer Patients |
NCT05289466 |
Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation. |
NCT04872166 |
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer |
NCT02871726 |
Transrectal Ultrasound Robot-Assisted Prostate Biopsy |
NCT06130826 |
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer |
NCT03769766 |
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance |
NCT04140526 |
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC |
NCT06420726 |
Resistance Exercise and Creatine in Colorectal Cancer |
NCT06633926 |
Integrative Approaches for Cancer Survivorship (IACS3) |
NCT06423326 |
Gemcitabine, Cisplatin and Nab-Paclitaxel As Neoadjuvant Treatment for Patients with Resectable or Borderline Resectable Pancreatic Cancer |
NCT05391126 |
GENOCARE: a Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care |
NCT05990426 |
Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy |
NCT05592626 |
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants with Advanced Solid Tumors |
NCT05183126 |
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer |
NCT06590857 |
Trial of 225Ac-DOTATATE (RYZ101) in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs. |
NCT06106282 |
Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) |
NCT05653882 |
A Study Evaluating AB248 Alone or in Combination with Pembrolizumab in Adult Patients with Solid Tumors |
NCT06428682 |
Role of TXA in Patients Undergoing Breast Free Flap Reconstruction |
NCT02451982 |
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas |
NCT04074720 |
Prospective Breast Cancer Biospecimen Collection |
NCT05634720 |
Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer |
NCT06412120 |
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib |
NCT05825482 |
Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout® |
NCT05958082 |
Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients with High-Risk Prostate Cancer |
NCT06202820 |
CV CARE: CardioVascular Care in PC Patients |
NCT05485974 |
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation |
NCT05799274 |
Safety of RAD301 in Healthy Human Volunteers and Patients with Pancreatic Cancer |
NCT02918474 |
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer |
NCT04421820 |
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours |
NCT05470920 |
Genetic Testing Decision Aid |
NCT06340620 |
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope |
NCT05828082 |
Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer |
NCT05568420 |
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC) |
NCT06545682 |
Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) |
NCT05563220 |
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer |
NCT04796220 |
Focused Ultrasound and Gemcitabine in Breast Cancer |
NCT06268665 |
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy |
NCT06744465 |
NearWave Optical Molecular Monitoring |
NCT05851365 |
Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer |
NCT00756665 |
Prostate Active Surveillance Study |
NCT05156866 |
First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer |
NCT06721065 |
A Study of Language Interpretation Solutions for People With Breast Cancer |
NCT04503265 |
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies |
NCT06799065 |
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer |
NCT06549465 |
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC) |
NCT04756765 |
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer |
NCT04275557 |
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas |
NCT05952557 |
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) |
NCT05047926 |
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients |
NCT06743126 |
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma |
NCT06402357 |
High Intensity Focused Ultrasound in Prostate Cancer |
NCT05227326 |
AOH1996 for the Treatment of Refractory Solid Tumors |
NCT02610426 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer |
NCT06817226 |
BREAST Choice Decision Tool R21 |
NCT06324357 |
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread |
NCT05573126 |
Phase 1/2 Study to Evaluate Vosilasarm (EP0062) as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer |
NCT02595957 |
Genomic Services Research Program |
NCT06533826 |
TReatment of ADC-Refractory Breast CancEr with Dato-DXd or T-DXd: TRADE DXd |
NCT05842057 |
Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy |
NCT06253520 |
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer |
NCT06639074 |
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients with Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial |
NCT05764720 |
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach |
NCT05305365 |
Study Assessing QBS72S for Treating Brain Metastases |
NCT05929820 |
Impact of Protect Your Colon™ on CRC Screening |
NCT05115474 |
Study of Screening Brain MRIs in Stage IV Breast Cancer |
NCT05268666 |
A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors |
NCT04841148 |
Avelumab or Hydroxychloroquine with or Without Palbociclib to Eliminate Dormant Breast Cancer |
NCT06483048 |
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer |
NCT06710548 |
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors |
NCT04768426 |
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer |
NCT06425926 |
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors |
NCT06026657 |
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells with or Without Naxitamab (Danyelza) for the Treatment of Patients with Metastatic, GD2 Expressing, HER2 Negative Breast Cancer |
NCT05461430 |
Mass Response of Tumor Cells As a Biomarker for Rapid Therapy Guidance (TraveraRTGx) |
NCT05870748 |
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 |
NCT05968157 |
MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick |
NCT04196257 |
BP1001-A in Patients With Advanced or Recurrent Solid Tumors |
NCT06044857 |
PSMA PET Response Guided SabR in High Risk Pca |
NCT04616248 |
In Situ Immunomodulation with CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients W/ Unresectable and Metastatic Solid Tumors |
NCT04678648 |
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies |
NCT03972657 |
A Trial to Find Out if REGN5678 is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors |
NCT05744557 |
Vapocoolant Analgesia for Breast Lymphoscintigraphy |
NCT06068257 |
Tumor-Derived FGF19 |
NCT03558048 |
The Effect of IBD Flares on Serum PSA |
NCT04565457 |
A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality |
NCT01042548 |
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum |
NCT03659448 |
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer |
NCT04991948 |
Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer |
NCT05766748 |
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer |
NCT05721248 |
STOP-HER2: Stopping Trastuzumab in HER2+ MBC |
NCT02016248 |
Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer |
NCT05948657 |
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr |
NCT04523857 |
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer |
NCT05085548 |
ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies |
NCT06249048 |
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab |
NCT04590326 |
A Trial to Find Out How Safe REGN5668 is and How Well it Works When Given With Either Cemiplimab or REGN4018 |
NCT00830557 |
Collecting Medical Information and Tissue Samples from Patients with Pancreatic Cancer or Other Pancreatic Disorders |
NCT02910557 |
Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection |
NCT05123482 |
A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies |
NCT05961982 |
Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study |
NCT06671782 |
A Study of a Pelvic Floor Muscle Exercise Program Before and After Radical Prostatectomy |
NCT05464082 |
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC |
NCT03866382 |
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors |
NCT05803382 |
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers |
NCT05669482 |
Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer |
NCT05746182 |
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms |
NCT03995082 |
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey |
NCT05806931 |
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer |
NCT05034627 |
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer |
NCT04240327 |
Marker Driven Selection of Patients for Prostate Biopsy and Management |
NCT03073694 |
Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis |
NCT06179160 |
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation |
NCT05665660 |
Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening |
NCT02861573 |
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) |
NCT04104776 |
A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas |
NCT06339827 |
ASk Questions in GYnecologic Oncology (ASQ-GYO) |
NCT04666727 |
Role of Diet on the Microbiome of the Digestive System |
NCT05546827 |
PRISM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal Melanoma |
NCT06646627 |
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors |
NCT04569773 |
Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer |
NCT04903873 |
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors |
NCT03861676 |
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT |
NCT04808427 |
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer |
NCT04471727 |
A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001) |
NCT02064673 |
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy |
NCT06524973 |
Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers |
NCT05440929 |
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians |
NCT05568680 |
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma |
NCT06267729 |
Study of AZD0754 in Participants With Metastatic Prostate Cancer |
NCT03930680 |
Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane |
NCT05272462 |
Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer |
NCT03704662 |
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma |
NCT05208762 |
A Study of SGN-PDL1V in Advanced Solid Tumors |
NCT04423029 |
A Study of DF6002 Alone and in Combination With Nivolumab |
NCT04919629 |
APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion |
NCT04562129 |
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients |
NCT06130280 |
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer |
NCT05544929 |
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers |
NCT05143229 |
Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer |
NCT06121180 |
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma |
NCT06445062 |
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors |
NCT04337580 |
Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer |
NCT06264180 |
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs (IGNYTE-3) |
NCT06413680 |
A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies |
NCT06651580 |
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study |
NCT05983380 |
The Effect of Hand Exercises on Upper Limb Volume, Quality of Life, and Hand Function in Breast Cancer Survivors |
NCT05710380 |
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy |
NCT05704062 |
Quantitative MRI Assessment of Breast Cancer Therapy Response |
NCT06022029 |
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. |
NCT04748380 |
Shared Decision-making and Colorectal Cancer Screening |
NCT04356729 |
A Phase II Trial of PD-L1 Therapy Combined with Anti-VEGF Therapy in Unresectable or Metastatic Melanoma |
NCT06708429 |
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System |
NCT05620329 |
UNC Pleural Fluid Registry |
NCT03879629 |
Treating Breast Cancer Patients Undergoing Trastuzumab Treatment with Carvedilol to Reduce Incidence of Heart Failure |
NCT05785780 |
Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings |
NCT05645380 |
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC |
NCT05735080 |
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer |
NCT04258280 |
Improving Genetic Counseling for BRCA+ Mothers |
NCT04722692 |
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ |
NCT06548789 |
Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED |
NCT04324294 |
Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions |
NCT05604560 |
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer |
NCT06056791 |
Study of INKmune in Patients With mCRPC (CaRe Prostate) |
NCT05593094 |
A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Patients With HER2-Positive Advanced Solid Tumors |
NCT04878094 |
A Study of Intra-operative Imaging in Women With Ovarian Cancer |
NCT05408260 |
A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer |
NCT04550494 |
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations |
NCT05478694 |
Outcomes of Focal Ablation for Prostate Cancer |
NCT05562791 |
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer |
NCT06396091 |
A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer |
NCT05422794 |
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer |
NCT05040360 |
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors |
NCT02400060 |
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients with Breast Cancer |
NCT05633160 |
64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) |
NCT05691491 |
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness |
NCT04930991 |
High Dose Omeprazole in Patients With Pancreatic Cancer |
NCT05766891 |
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery |
NCT04815876 |
PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2 |
NCT04824027 |
Breast Elasticity Imaging During Neoadjuvant Chemotherapy |
NCT00001276 |
Diagnosing and Treating Low Blood Sugar Levels |
NCT06508827 |
Intravenous Iron in Combination with Standard of Care Immunotherapy in Melanoma |
NCT05349227 |
Comprehensive Outcomes for After Cancer Health |
NCT05812027 |
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors |
NCT06620627 |
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection |
NCT06081127 |
Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and Function |
NCT04839991 |
Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours. |
NCT03971591 |
Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors |
NCT05613894 |
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer |
NCT05910294 |
A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer |
NCT05608291 |
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery |
NCT06750094 |
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy |
NCT05417594 |
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies |
NCT05411094 |
Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer |
NCT06686394 |
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009) |
NCT06253494 |
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer |
NCT04147494 |
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues |
NCT03485794 |
Collection of Blood in Studying Metabolites in Patients With Prostate Cancer |
NCT06276491 |
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors |
NCT05629494 |
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test |
NCT05535894 |
Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer |
NCT05483491 |
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer |
NCT05000294 |
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types |
NCT05150691 |
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors |
NCT06608927 |
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma |
NCT06318273 |
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer |
NCT05340673 |
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer |
NCT04175431 |
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study |
NCT05092373 |
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax |
NCT05319873 |
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer |
NCT05484973 |
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss |
NCT06471673 |
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer |
NCT06172127 |
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer |
NCT06599476 |
Rectal Spacers in Prostate Cancer Patients Undergoing Radiation Therapy |
NCT05856773 |
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy |
NCT06402331 |
FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
NCT05556473 |
F-Tryptophan PET/CT in Human Cancers |
NCT05903131 |
A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia |
NCT04886531 |
Trial of Pre-operative Neratinib and Endocrine Therapy with Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers |
NCT06294873 |
Stool Sample Collection Study |
NCT04573231 |
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer |
NCT03562273 |
GammaPod Registry and Quality of Life Nomogram |
NCT06450873 |
Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery |
NCT06593431 |
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial |
NCT03746431 |
A Phase 1/2 Study of [225Ac]-FPI-1434 Injection |
NCT05611931 |
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma |
NCT05888831 |
A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors |
NCT05497531 |
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers |
NCT05869682 |
Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy |
NCT05994482 |
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study |
NCT04297020 |
Brain Health in Breast Cancer Survivors |
NCT06146920 |
Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation |
NCT03909282 |
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma |
NCT04771520 |
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors |
NCT06188520 |
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors |
NCT06636682 |
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer |
NCT02361320 |
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer |
NCT06545331 |
Study of XB010 in Subjects With Solid Tumors |
NCT04406831 |
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer |
NCT05965180 |
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe |
NCT02926729 |
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy |
NCT06194929 |
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma |
NCT04662580 |
ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer |
NCT06673329 |
Brodalumab in the Treatment of Immune-Related Adverse Events |
NCT03692429 |
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells |
NCT04134780 |
Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response |
NCT03151629 |
International Registry for Men With Advanced Prostate Cancer (IRONMAN) |
NCT06638294 |
Study in Patients With Breast Cancer Leptomeningeal Metastasis |
NCT05608694 |
MRI Screening in Men at High Risk of Developing Prostate Cancer |
NCT06239194 |
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors |
NCT05396794 |
Bariatric Education for Women With Obesity and Endometrial Cancer |
NCT06432660 |
Eye Plaque Brachytherapy for Ocular Melanoma |
NCT03876860 |
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis |
NCT04134260 |
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer |
NCT05627960 |
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies |
NCT00991094 |
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated with Proton Therapy |
NCT05969860 |
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients with Advanced Cancer |
NCT05586360 |
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer |
NCT04329494 |
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer |
NCT06315491 |
A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer |
NCT06271291 |
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts |
NCT04614194 |
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib |
NCT06594991 |
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma |
NCT06411691 |
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer |
NCT06120491 |
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents |
NCT04473794 |
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts |
NCT05467891 |
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer |
NCT05959291 |
Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer |
NCT04754191 |
Enfortumab Vedotin As Monotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer |
NCT04609592 |
Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery |
NCT05846789 |
SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers |
NCT05625529 |
ExoLuminate Study for Early Detection of Pancreatic Cancer |
NCT04510129 |
A Multicenter Cancer Biospecimen Collection Study |
NCT05919329 |
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy |
NCT06751329 |
A Study of DM002 in Patients With Advanced Solid Tumors |
NCT06435429 |
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer |
NCT05496829 |
IMPACT Trial: Intervention to IMProve AdherenCe Equitably |
NCT04294927 |
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention |
NCT06023576 |
A Study of Blood Pressure Control During Cancer Treatment |
NCT03495427 |
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores |
NCT01638676 |
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients |
NCT06312176 |
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) |
NCT05477576 |
Study of RYZ101 Compared with SOC in Pts W Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy |
NCT04709276 |
A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer |
NCT04697576 |
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma |
NCT06780176 |
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida |
NCT04967976 |
Breast Mesh Used in Two-staged Breast Reconstruction |
NCT04090567 |
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer |
NCT06046040 |
TmPSMA-02 in mCRPC |
NCT05372640 |
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors |
NCT03564340 |
Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers |
NCT06342440 |
Early Detection of Advanced Adenomas and Colorectal Cancer |
NCT05537740 |
A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors |
NCT05242744 |
FTT PET/CT in Metastatic Prostate Cancer |
NCT04956640 |
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) |
NCT02402244 |
Project: Every Child for Younger Patients With Cancer |
NCT02584244 |
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers |
NCT05968144 |
Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness |
NCT06849544 |
Phase II Trial to Investigate the Safety and Efficacy of Three Dosing Regimens of OTL78 Injection |
NCT04475640 |
Cancer Genetic Testing in Ethnic Populations |
NCT04879940 |
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization |
NCT05059444 |
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation |
NCT05877144 |
LiSWT for Nerve Sparing Radical Prostatectomy ED |
NCT03804944 |
Converting HR+ Breast Cancer Into an Individualized Vaccine |
NCT04282044 |
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies |
NCT05130840 |
Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer |
NCT05367440 |
Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer |
NCT06595160 |
Association of Plant-based Diet and Gut Microbiome Signature with Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma |
NCT05076760 |
MEM-288 Oncolytic Virus Alone and in Combination With Nivolumab in Solid Tumors Including Non-Small Cell Lung Cancer |
NCT05020860 |
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer |
NCT06401889 |
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy |
NCT06485089 |
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers |
NCT06171789 |
PRO1107 in Patients With Advanced Solid Tumors |
NCT05896189 |
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors |
NCT06399276 |
4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity |
NCT05698576 |
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer |
NCT04701476 |
TATE and Pembrolizumab (MK3475) in mCRC and NSCLC |
NCT06152276 |
SafeHeal Diverting Ileostomy Pivotal Study |
NCT06586957 |
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors |
NCT03568448 |
Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging |
NCT04443348 |
Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) |
NCT02632448 |
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer |
NCT05752448 |
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O) |
NCT06137248 |
Study to Assess Colonic Microbiota Changes in Response to Energy Drink Consumption |
NCT05464030 |
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) |
NCT04084730 |
Study of 3-Day Partial Breast Radiation Therapy in Women with Breast Cancer |
NCT03568630 |
Blood Markers of Early Pancreas Cancer |
NCT04734730 |
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer |
NCT05283330 |
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors |
NCT06507930 |
The COMPASSION Study |
NCT06307548 |
Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer |
NCT05877430 |
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer |
NCT05037825 |
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors |
NCT05810025 |
FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments |
NCT04360330 |
SABER Study for Selected Early Stage Breast Cancer |
NCT06805825 |
A Study of the C-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced And/or Metastatic Solid Tumors Known to Express C-Kit |
NCT05673148 |
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, the ERASur Study |
NCT04941430 |
7T MRI Scan for the Early Detection of Melanoma Brain Metastases |
NCT06056830 |
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants with High-risk Prostate Cancer Prior to Radical Prostatectomy |
NCT03203525 |
Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer |
NCT05746325 |
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast Cancer |
NCT06297525 |
Study of STP938 in Advanced Solid Tumours |
NCT01937039 |
Johns Hopkins Breast Cancer Program Longitudinal Repository |
NCT06065748 |
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) |
NCT05799248 |
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management |
NCT05669430 |
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies |
NCT05634525 |
Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients |
NCT06534125 |
Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women with Early-Stage Breast Cancer |
NCT06385925 |
A Study of TSN1611 Treating Patients with Advanced Solid Tumors Harboring KRAS G12D Mutation |
NCT04263025 |
AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft |
NCT06657222 |
First in Human Study of TUB-030 in Patients with Advanced Solid Tumors |
NCT05896839 |
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer |
NCT06128525 |
Prostate Resection After Microwave Ablation (PRAMA) |
NCT05928325 |
Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults with Stage I-III Breast Cancer Who Have Completed Curative Treatment |
NCT03589339 |
NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD-1 Therapy |
NCT05412225 |
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer |
NCT06492122 |
Study With [225Ac]Ac-FL-020 in mCRPC Participants |
NCT05231122 |
Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer |
NCT06030622 |
Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer |
NCT06040125 |
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial |
NCT03745326 |
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients |
NCT05045066 |
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients |
NCT05267626 |
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer |
NCT03090165 |
Ribociclib and Bicalutamide in AR+ TNBC |
NCT03048266 |
Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients |
NCT04198766 |
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) |
NCT05756166 |
Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer |
NCT05036226 |
COAST Therapy in Advanced Solid Tumors and Prostate Cancer |
NCT05948826 |
First in Human Study of TORL-3-600 in Participants With Advanced Cancer |
NCT06297265 |
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery |
NCT06295965 |
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study |
NCT06734130 |
Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer |
NCT03351348 |
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control |
NCT04052048 |
Active Surveillance SNEP Assay Registry Trial for Prostate Cancer |
NCT04606030 |
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge) |
NCT05538130 |
A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors |
NCT06610825 |
Castrate Resistant Prostate Cancer Enhertu Therapy |
NCT05053230 |
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer |
NCT03524430 |
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy |
NCT03767348 |
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab |
NCT04039230 |
Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. |
NCT06605430 |
Medical Cannabis in Patients With Advanced Pancreatic Cancer |
NCT05539430 |
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma |
NCT05868226 |
PRE-I-SPY Phase I/Ib Oncology Platform Program |
NCT06275126 |
Optimizing Surgical Decisions in Young Adults With Breast Cancer |
NCT04752826 |
BI-1808 As a Single Agent and with Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) |
NCT05879926 |
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 |
NCT06518057 |
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer |
NCT06557148 |
A Study Comparing Cancer Imaging Approaches in People with Lobular Breast Cancer |
NCT06336148 |
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors |
NCT06358430 |
Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD) |
NCT04346225 |
Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer |
NCT06044025 |
A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy |
NCT06119425 |
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands |
NCT06449222 |
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy |
NCT06870539 |
Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment |
NCT04918186 |
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer |
NCT06171139 |
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer |
NCT04797039 |
MRI-Guided Cryoablation for Focal Native Prostate Cancer |
NCT06398639 |
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer |
NCT03333122 |
Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes |
NCT05478239 |
ArtemiCoffee in Patients With Rising PSA |
NCT05678322 |
Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy |
NCT04871139 |
An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer |
NCT06479239 |
Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer |
NCT04511039 |
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer |
NCT03104439 |
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer |
NCT06262139 |
Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients |
NCT06129422 |
Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer |
NCT05783622 |
Study of JANX008 in Subjects with Advanced or Metastatic Solid Tumor Malignancies |
NCT05051722 |
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer |
NCT04633239 |
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer |
NCT01788839 |
Longitudinal Sexual and Reproductive Health Study of Women with Breast Cancer and Lymphoma |
NCT00451022 |
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies |
NCT06022822 |
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial |
NCT01915225 |
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer |
NCT05400122 |
Natural Killer (NK) Cells in Combination with Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer |
NCT05651022 |
Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors |
NCT05553522 |
Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer |
NCT05223322 |
Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction |
NCT04847063 |
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies |
NCT06059963 |
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation |
NCT06115486 |
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer |
NCT06300463 |
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases |
NCT05528263 |
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial) |
NCT03677739 |
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families |
NCT06662786 |
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer |
NCT05174286 |
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk |
NCT06384222 |
Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone |
NCT06388122 |
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients |
NCT03880422 |
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors |
NCT05238922 |
Study of INCB123667 in Subjects With Advanced Solid Tumors |
NCT06028022 |
Reishi Mushroom Extract for Fatigue And/or Arthralgias/myalgias in Patients with Breast Cancer on Aromatase Inhibitors |
NCT03539822 |
Cabozantinib Plus Durvalumab with or Without Tremelimumab in Patients with Gastroesophageal Cancer and Other Gastrointestinal Malignancies |
NCT02960022 |
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study |
NCT06879522 |
Maximizing Energy and Reducing Fatigue in Breast Cancer Survivors |
NCT04430725 |
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study |
NCT06654622 |
Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer |
NCT05922930 |
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer |
NCT03147430 |
Early Detection of Breast Cancer in Women With Suspicious Mammograms |
NCT06806930 |
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT) |
NCT05488548 |
Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies |
NCT06671730 |
Self-Determination Theory-informed Occupational Therapy Program to Increase Physical Activity Among Survivors of Breast Cancer |
NCT04588025 |
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response |
NCT06158139 |
Autologous CAR-T Cells Targeting B7-H3 in PDAC |
NCT06055439 |
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy |
NCT06666439 |
Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer |
NCT05832086 |
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes |
NCT05720039 |
Robotic vs. Open NSM for Early Stage Breast Cancer |
NCT05894239 |
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer |
NCT04234386 |
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer |
NCT05256225 |
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma |
NCT03129139 |
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors |
NCT05900986 |
LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer |
NCT05768139 |
First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors |
NCT03678025 |
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer |
NCT05455658 |
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer |
NCT06542835 |
Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity |
NCT04331535 |
The Genomic Medicine at VA Study |
NCT06162663 |
Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors |
NCT04887935 |
Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer |
NCT04799535 |
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring |
NCT06617858 |
Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment |
NCT03382158 |
International PPB/DICER1 Registry |
NCT03526835 |
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors |
NCT05524935 |
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma |
NCT06192758 |
Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device |
NCT05304858 |
Tumor Microenvironment Analysis of Prostate Cancer Metastasis |
NCT06441474 |
Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women |
NCT05902520 |
Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors |
NCT06625320 |
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) |
NCT02749474 |
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes |
NCT04567420 |
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE) |
NCT05111574 |
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery |
NCT04471974 |
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
NCT06217874 |
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer |
NCT06393374 |
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) |
NCT05458674 |
Tucatinib+Trastuzumab+Eribulin in HER2+ MBC |
NCT05585320 |
A Phase 1/2a Study of IMM-1-104 in Participants With Previously Treated, RAS-Mutant, Advanced or Metastatic Solid Tumors |
NCT02743858 |
Lymphedema Surveillance Study |
NCT06797635 |
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) |
NCT06132958 |
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005) |
NCT05754658 |
African Cancer Genome: GMD |
NCT04585958 |
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer |
NCT04998682 |
Prospective Evaluation of Targeted Axillary Dissection (TAD) |
NCT05912231 |
Ultrahypofractionation and Normal Tissue Toxicity |
NCT03161431 |
SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab |
NCT05006131 |
Pancreatic Cancer Screening for At-risk Individuals |
NCT05770531 |
Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy |
NCT03127631 |
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients |
NCT05736731 |
A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants with Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression |
NCT05361174 |
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer |
NCT05983276 |
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer |
NCT05721976 |
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study |
NCT04394676 |
The Impact of Low Pressure Pneumo in RARP II |
NCT04862663 |
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292) |
NCT05438563 |
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Intermediate Grade Prostate Cancer |
NCT03454035 |
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors |
NCT05384535 |
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort |
NCT06250335 |
Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients |
NCT03439735 |
Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC |
NCT06691035 |
Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer |
NCT02189486 |
Prostate Cancer Upgrading Reference Set |
NCT06788886 |
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases |
NCT06294886 |
Vaginal Fluid Collection for Detection of Endometrial Cancer |
NCT06557057 |
Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk |
NCT06399757 |
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors |
NCT06675357 |
Using FAPI PET/MRI to Evaluate Prostate Cancer |
NCT03863457 |
[18F] F-GLN by PET/CT in Breast Cancer |
NCT04561362 |
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies |
NCT05077280 |
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma |
NCT06252662 |
Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies |
NCT05642962 |
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) |
NCT02000089 |
The Cancer of the Pancreas Screening-5 CAPS5)Study |
NCT04840589 |
Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors |
NCT03567889 |
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients |
NCT06157892 |
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors |
NCT06245889 |
PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC |
NCT04599140 |
SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial |
NCT06568562 |
XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer |
NCT05932862 |
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Patients With Advanced Solid Tumors |
NCT00539162 |
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women |
NCT06447662 |
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. |
NCT06173362 |
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer |
NCT05304962 |
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer |
NCT05313191 |
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors |
NCT05654246 |
Susan G. Komen's ShareForCures |
NCT05155046 |
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy |
NCT06882746 |
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas |
NCT06907446 |
Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies |
NCT05049746 |
Identifying Decision Making Needs for Older Adult Women with Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy |
NCT06518746 |
Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation |
NCT06378346 |
GU-01: Glycyrrhizin in Prostate Cancer |
NCT06503146 |
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection |
NCT06079346 |
A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer |
NCT05094804 |
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents |
NCT05396872 |
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer |
NCT04588662 |
A Prospective Natural History Study in Uveal Melanoma |
NCT06767462 |
An Ophthalmic Safety Study in Patients With Breast Cancer |
NCT03065062 |
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors |
NCT06070012 |
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma |
NCT06671912 |
Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial |
NCT04754412 |
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study |
NCT05839912 |
Excision of Lymph Node Trial (EXCILYNT) (Mel69) |
NCT05479812 |
Dose Escalation and Expansion Study of WTX-124 As Monotherapy and in Combination with Pembrolizumab (pembro) in Patients with Selected Advanced or Metastatic Solid Tumors |
NCT03832855 |
Assessing the Immunogenicity of pING-hHER3FL |
NCT06136650 |
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) |
NCT06400550 |
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis |
NCT06054555 |
A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma |
NCT06461650 |
Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction |
NCT05754580 |
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer |
NCT04684862 |
Infusion System for Hepatic Cancer |
NCT03991962 |
Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma |
NCT06369246 |
PRORAD-5 PROstate RADiation in 5 Fractions: Phase Ib Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer |
NCT05629546 |
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors |
NCT03709446 |
Leflunomide in Previously Treated Metastatic Triple Negative Cancers |
NCT05534646 |
Study of Apalutamide with Carotuximab in Metastatic, Castration-Resistant Prostate Cancer |
NCT04989946 |
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer |
NCT03821935 |
Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors |
NCT06756035 |
CT-95 in Advanced Cancers Associated with Mesothelin Expression |
NCT06238986 |
Relationship Between Alterations in the GI Microbiome and GI Inflammation on Symptom Burden in Women with Breast Cancer Receiving Chemotherapy |
NCT06037863 |
Evaluation of the Impact of Empty Versus Full Bladder in Patients with Prostate Cancer, RELIEF Trial |
NCT05225363 |
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer |
NCT04927663 |
11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression |
NCT04575935 |
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial |
NCT04706663 |
Precision-Based Genomics in Prostate Cancer |
NCT05918263 |
Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial |
NCT05850663 |
Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer |
NCT06423963 |
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer |
NCT05998135 |
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer |
NCT06820463 |
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer |
NCT05428735 |
The DRAGON 2 Trial |
NCT02896335 |
Palbociclib and Pembrolizumab in Central Nervous System Metastases |
NCT05463796 |
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer |
NCT04568616 |
Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) |
NCT06314958 |
Stage II/III Colorectal Cancer Recurrence |
NCT05377996 |
A Study of XMT-1660 in Participants With Solid Tumors |
NCT06551116 |
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer |
NCT06703996 |
InBody Band 3 Fitness Tracker to Improve Health Outcomes and Quality of Life in Black Prostate Cancer Survivors |
NCT05036096 |
Cone Beam Breast CT for Breast Cancer Screening |
NCT05838716 |
High-Dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients |
NCT06584396 |
Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study |
NCT04997096 |
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy |
NCT04130516 |
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and with Pembrolizumab |
NCT06246916 |
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma |
NCT06428396 |
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) |
NCT04251416 |
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma |
NCT03819296 |
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer |
NCT00034216 |
Collection of Blood From Patients With Cancer |
NCT06326216 |
Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer |
NCT02611024 |
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors |
NCT06466434 |
Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma |
NCT04981834 |
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer |
NCT04305834 |
Abemaciclib and Endocrine Therapy in Older Patients with Breast Cancer. |
NCT05514717 |
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 |
NCT06639724 |
Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer |
NCT02290834 |
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer |
NCT04961996 |
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) |
NCT06364696 |
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors |
NCT06566716 |
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass |
NCT05692596 |
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics |
NCT04022616 |
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients |
NCT05946824 |
This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned. |
NCT06704724 |
A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene |
NCT05268224 |
A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue |
NCT05297734 |
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer |
NCT04898634 |
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer |
NCT06219434 |
Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast Cancer |
NCT06298734 |
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial |
NCT06011434 |
Testing Conversation Aid in Practice |
NCT03540017 |
HIPEC After Initial CRS in Patients Who Have Received NACT |
NCT05356117 |
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial |
NCT05305924 |
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer |
NCT05751434 |
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer |
NCT03492424 |
Ablative Therapy in the Management of Prostate Cancer |
NCT05692024 |
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER |
NCT03965234 |
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases |
NCT03784924 |
EDRN Prostate MRI Biomarker Study |
NCT05170334 |
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma |
NCT05812924 |
A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause |
NCT04267796 |
Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women |
NCT05125016 |
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer |
NCT03354416 |
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer |
NCT05981716 |
Young Breast Cancer Survivors Study |
NCT05830058 |
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma |
NCT06492616 |
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence |
NCT02830724 |
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers |
NCT04858334 |
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation |
NCT05054296 |
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring |
NCT05930496 |
Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors |
NCT05548296 |
A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma |
NCT05864196 |
Two Fraction Prostate SBRT With DIL SIB |
NCT06623396 |
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer |
NCT03990896 |
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial |
NCT06555796 |
Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer |
NCT06090916 |
Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer |
NCT06122896 |
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals |
NCT05384496 |
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma |
NCT04789486 |
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer |
NCT04792463 |
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome |
NCT04914663 |
All-extremity Exercise During Breast Cancer Chemotherapy |
NCT06389786 |
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer |
NCT05652686 |
A Study of Peluntamig (PT217) in Patients with Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) |
NCT04158635 |
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer |
NCT06774963 |
A Phase 1 Study of LNCB74 in Advanced Solid Tumors |
NCT02476786 |
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score |
NCT05496686 |
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma |
NCT03420963 |
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors |
NCT05840263 |
Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer |
NCT06014086 |
Intratumoral PH-762 for Cutaneous Carcinoma |
NCT05628363 |
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer |
NCT04711824 |
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases |
NCT05565417 |
Study of the Monoclonal Antibody IMT-009 in Patients with Advanced Solid Tumors or Lymphomas |
NCT06410534 |
A Phase II Study Evaluating an Organ Preservation Strategy Using Immune Checkpoint Blockade for Participants With Primary Colorectal or Gastroesophageal Cancer |
NCT05321134 |
Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery |
NCT03772834 |
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients with Prostate Cancer |
NCT04119024 |
Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors |
NCT05607017 |
Losartan in Prevention of Radiation-Induced Heart Failure |
NCT05776524 |
Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer |
NCT05497024 |
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing |
NCT05565534 |
Diabetes Care for Breast Cancer Patients |
NCT06391034 |
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer |
NCT05743517 |
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) |
NCT06274034 |
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors |
NCT06625034 |
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer |
NCT03646617 |
Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma |
NCT06193486 |
Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC |
NCT06299163 |
NM32-2668 in Adult Patients with Selected Advanced Solid Tumors |
NCT06287463 |
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway |
NCT05226663 |
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer |
NCT04074135 |
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors |
NCT05574686 |
Telemonitoring Hypertension and Breast Cancer |
NCT06400563 |
MRg-NIRS Imaging System Breast Cancer Trial |
NCT06421935 |
M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501) |
NCT04969835 |
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours |
NCT06778863 |
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation |
NCT04115163 |
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer |
NCT06100263 |
Breast Cancer Resiliency Through Exercise Program (B-REP) |
NCT06662435 |
GYNecologic Cancer-Related COGnitive Impairment |
NCT04751435 |
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients |
NCT04188535 |
Serial MRI Scans During Radiation Therapy |
NCT05610735 |
Combination Therapy for Recurrent Ovarian Cancer |
NCT06500858 |
MBC Physical Activity Study |
NCT05787834 |
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer |
NCT06291324 |
WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment |
NCT05468034 |
Exercise in Metastatic Breast Cancer: EMBody |
NCT04825834 |
DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) |
NCT05748834 |
Study of Tucatinib and Doxil in Participants with Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer |
NCT06582017 |
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma |
NCT06075524 |
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types |
NCT04646434 |
Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical Prostatectomy |
NCT06011824 |
A Study of Effect of Megakaryocytes and Platelets in Breast Cancer |
NCT06136624 |
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) |
NCT04677816 |
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients |
NCT06113016 |
Prevention of Frailty with Fisetin and Exercise (PROFFi) in Breast Cancer Survivors |
NCT05641896 |
Study of [18F]FAPI-74 PET in Patients with Gastrointestinal Cancers |
NCT05576896 |
Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory |
NCT06798558 |
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy |
NCT04715958 |
Prediction of Neoadjuvant Chemotherapy Response Using Contrast-Enhanced Ultrasound in Patients With Locally Advanced Breast Cancer |
NCT00291096 |
High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer |
NCT06315296 |
An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer |
NCT04457596 |
T-DM1 and Tucatinib Compared with T-DM1 Alone in Preventing Relapses in People with High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial |
NCT04751396 |
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors |
NCT05142358 |
A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose |
NCT06247995 |
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor. |
NCT05739981 |
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
NCT06084481 |
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 |
NCT05999812 |
Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer |
NCT06494046 |
Defining Musical Toxicity and Its Effect on Patient Well-being |
NCT06027268 |
Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer |
NCT04606446 |
Study of PF-07248144 in Advanced or Metastatic Solid Tumors |
NCT05469269 |
Cleveland African American Prostate Cancer Project |
NCT02977468 |
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer |
NCT04365569 |
Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program |
NCT05755269 |
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women |
NCT04739072 |
Minimal Residual Disease Assessment in Patients with Colorectal Cancer, the MiRDA-C Study |
NCT06347068 |
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells |
NCT06444269 |
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial |
NCT04905069 |
Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy |
NCT06844669 |
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy |
NCT04891068 |
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer |
NCT06099769 |
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer |
NCT02332668 |
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) |
NCT06833268 |
Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab Deruxtecan |
NCT03228667 |
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors |
NCT04994067 |
Intra-Operative Radiation Registry |
NCT05155501 |
Clinical Trial of Approaches to Prostate Cancer Surgery |
NCT06710067 |
Urine Metabolites in the Diagnosis of Disease |
NCT04783467 |
Time Restricted Eating (TRE) Among Endometrial Cancer Patients |
NCT05795101 |
TRUDI: TDXD+Durva in HER2+/low IBC |
NCT05464667 |
Preoperative Irradiation for Stage I Breast Cancer |
NCT06239467 |
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer |
NCT05837767 |
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue |
NCT06697301 |
Safety and Efficacy of EIK1001-006 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. |
NCT05736367 |
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer |
NCT05554367 |
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial |
NCT05355701 |
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. |
NCT06521567 |
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer |
NCT05130801 |
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery |
NCT06824467 |
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103) |
NCT04349501 |
Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI) |
NCT04674267 |
Resilience and Equity in Aging, Cancer, and Health (REACH) |
NCT04703244 |
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer |
NCT05819892 |
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer |
NCT05376592 |
Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma |
NCT05705492 |
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer |
NCT05498792 |
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma |
NCT06346067 |
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) |
NCT04631744 |
Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) |
NCT02870244 |
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes |
NCT04512144 |
Mindfulness in Endometrial and Cervical Cancer |
NCT04787744 |
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer |
NCT06568692 |
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer |
NCT01954992 |
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer |
NCT06229392 |
A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer |
NCT05912244 |
A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma |
NCT05864144 |
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors |
NCT04106492 |
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors |
NCT05472792 |
Adjuvant Monotherapy With Endocrine Therapy or Accelerated Partial Breast Irradiation Following Lumpectomy for Low Risk Breast Cancer Patients Over 65 (CAMERAN) |
NCT06533644 |
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer |
NCT05345444 |
Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) |
NCT04009044 |
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast |
NCT05056844 |
Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge |
NCT06733350 |
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance |
NCT06730750 |
A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors |
NCT05248581 |
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases |
NCT05691010 |
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer |
NCT06572410 |
Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision |
NCT06111781 |
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer |
NCT06658912 |
Planning Grant for TOPS for African American Breast Cancer Survivors |
NCT06305312 |
Community Services Navigation to Advance Health Equity in Breast Cancer Screening |
NCT06612281 |
Evaluation of Gixam's Performance in a FIT Negative Population |
NCT06173310 |
DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer |
NCT06749210 |
DAANCE for CHEMOTHERAPY-INDUCED NEUROPATHY |
NCT02040610 |
Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer |
NCT04877912 |
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening |
NCT05269381 |
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors |
NCT06516510 |
A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer |
NCT05435495 |
Mechanisms of Resistance to PSMA Radioligand Therapy |
NCT05138510 |
Sexual Health in Breast Cancer Patients |
NCT05979610 |
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies |
NCT05705401 |
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer |
NCT04474301 |
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic |
NCT05417867 |
Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer |
NCT05039801 |
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors |
NCT05964504 |
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry) |
NCT05581004 |
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors |
NCT05112601 |
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma |
NCT04104672 |
A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies |
NCT01950572 |
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma |
NCT05907304 |
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations |
NCT05501704 |
ETHAN - ET for Male BC |
NCT05751668 |
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) |
NCT05838768 |
Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. |
NCT05797168 |
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors |
NCT06246968 |
A Study of Pembrolizumab and Cryoablation in People with Breast Cancer |
NCT06215469 |
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) |
NCT06228768 |
Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer |
NCT05396846 |
My Best GI Eating Study |
NCT06340646 |
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) |
NCT01365169 |
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" |
NCT05789069 |
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors |
NCT03611868 |
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors |
NCT06678269 |
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer |
NCT06171269 |
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life |
NCT06465069 |
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors |
NCT06103669 |
Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS) |
NCT06067269 |
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients with Prostate Cancer, HEATWAVE Trial |
NCT01102569 |
Pancreatic Cancer Genetics |
NCT05113368 |
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer |
NCT03460769 |
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) |
NCT05929768 |
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer |
NCT04611568 |
War on Melanoma™ Public Health & Education Campaign |
NCT03050268 |
Familial Investigations of Childhood Cancer Predisposition |
NCT06129604 |
Pilot Window of Opportunity Trial (POET) |
NCT06342401 |
Early Onset Colorectal Cancer Detection |
NCT04854304 |
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts |
NCT02279004 |
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care |
NCT04868604 |
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) |
NCT05727904 |
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. |
NCT06745804 |
Study of 68Ga-R10602 |
NCT02021604 |
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma |
NCT04314401 |
National Cancer Institute "Cancer Moonshot Biobank" |
NCT05535192 |
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients |
NCT06562192 |
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers |
NCT03919292 |
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca |
NCT05458544 |
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application |
NCT06764940 |
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients with Brain Metastases |
NCT05726292 |
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer |
NCT05218044 |
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ |
NCT06083844 |
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy |
NCT03671044 |
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients |
NCT05607004 |
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer |
NCT01834001 |
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy |
NCT05046301 |
Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications |
NCT02772367 |
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients |
NCT06388967 |
Pancreatic Cancer Detection Consortium |
NCT06643767 |
Evaluation of the Bexa Breast Examination |
NCT05023967 |
Metformin and Nightly Fasting in Women With Early Breast Cancer |
NCT03606967 |
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer |
NCT05684367 |
Exercise to ReGain Stamina and Energy (The EXERGISE Study) |
NCT04580667 |
Prospective Observational Exploratory Clinical Study to Determine the Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict Gastrointestinal Radiation Toxicity Using Circulating Cell Free DNA Directly From Plasma |
NCT06538389 |
High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer |
NCT06092892 |
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients with Breast Cancer with Nodal Metastases |
NCT06392789 |
A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors |
NCT05946213 |
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer |
NCT04997018 |
A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer |
NCT06303713 |
LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer |
NCT06084013 |
Use of Indocyanine Green in Pancreas Surgery |
NCT02610413 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer |
NCT05879913 |
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT |
NCT05054413 |
Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method |
NCT01961713 |
Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy |
NCT06800313 |
A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) |
NCT06060613 |
Safety and Efficacy of OBX-115 in Advanced Solid Tumors |
NCT04222413 |
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors |
NCT05804318 |
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer |
NCT04796818 |
An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response |
NCT05624918 |
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma |
NCT04038619 |
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients |
NCT04340141 |
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer |
NCT06117241 |
Reducing Metabolic Dysregulation in Dyads |
NCT06599619 |
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi |
NCT05455619 |
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Women With a PI3K Alteration and HR+/Her2- Breast Cancer |
NCT05411718 |
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome |
NCT05683418 |
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults with Select Solid Tumors |
NCT05637216 |
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients |
NCT05914116 |
A Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors |
NCT04647916 |
Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases |
NCT05462496 |
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer |
NCT06084416 |
A Study of Sovilnesib in Subjects with Ovarian Cancer |
NCT06205316 |
SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma |
NCT04794816 |
What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care |
NCT03467516 |
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma |
NCT05980416 |
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 |
NCT06551324 |
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). |
NCT04513717 |
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial |
NCT06379217 |
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. |
NCT05415917 |
Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy |
NCT06150417 |
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) |
NCT06610617 |
Neuromodulation of Central Sensory Integration to Improve Postural Control |
NCT05838417 |
Promoting Informed Choice for Breast Cancer Screening: a Longitudinal Study |
NCT05997017 |
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer |
NCT04975217 |
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer |
NCT04548817 |
Neurocutaneous Melanocytosis Registry |
NCT06736717 |
Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer |
NCT04318717 |
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma |
NCT05989724 |
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors |
NCT05716516 |
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER) |
NCT05232916 |
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects |
NCT05590624 |
Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer |
NCT06312124 |
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer |
NCT04830124 |
Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6 |
NCT06208124 |
A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors |
NCT05646316 |
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer |
NCT06461416 |
A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework |
NCT06925724 |
A Study of Ivonescimab in People With Endometrial and Cervical Cancers |
NCT05351424 |
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc |
NCT03175224 |
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors |
NCT03686124 |
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors |
NCT04943536 |
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer |
NCT03474913 |
Upright MRI for Prostate Cancer Screening |
NCT05627219 |
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network |
NCT06663319 |
A Study of JNJ-89402638 for Metastatic Colorectal Cancer |
NCT06388018 |
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer |
NCT04692818 |
3D Ultrasound Breast Imaging |
NCT05636618 |
Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors |
NCT06507618 |
Pre-Operative Window of ET to Inform RT Decisions (POWER II) |
NCT01050504 |
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer |
NCT06605404 |
Pan-tumor MRD Study |
NCT04648904 |
Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer |
NCT06418204 |
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics |
NCT06244004 |
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial |
NCT06086704 |
Study of 18F-FFNP Breast PET/MRI |
NCT00899301 |
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer |
NCT05132504 |
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer |
NCT02333604 |
Cancer Experience Registry (CER) for Cancer Patients and Caregivers |
NCT06376604 |
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies |
NCT06394804 |
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer |
NCT04576104 |
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer |
NCT06388304 |
THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence |
NCT04829604 |
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03) |
NCT05691504 |
Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers |
NCT05919108 |
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers |
NCT05417308 |
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer |
NCT06106308 |
Study of Onvansertib in Combination with FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants with a KRAS or NRAS Mutation |
NCT06476808 |
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. |
NCT04354246 |
COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies |
NCT06500169 |
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors |
NCT06042569 |
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial |
NCT06362369 |
A Study of Oral 7HP349 (Alintegimod) in Combination with Ipilimumab Followed by Nivolumab Monotherapy |
NCT06408168 |
Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial) |
NCT05712668 |
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors |
NCT05868668 |
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain |
NCT06001268 |
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS) |
NCT02526368 |
Pilot Study of (MR) Imaging with Pyruvate (13C) to Detect High Grade Prostate Cancer |
NCT04589468 |
Researching the Effect of Exercise on Cancer |
NCT05490472 |
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors |
NCT06817668 |
Evaluating Tolerability of EPUHRT with Brachytherapy Boost |
NCT05546268 |
Study of Oral MRT-2359 in Selected Cancer Patients |
NCT06465368 |
A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause |
NCT04644068 |
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies |
NCT05892068 |
A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain |
NCT06915168 |
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer |
NCT04657068 |
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors |
NCT06182072 |
ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC) |
NCT05649072 |
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. |
NCT05334069 |
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection |
NCT06835569 |
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations |
NCT04687969 |
Multimodal Machine Learning Characterization of Solid Tumors |
NCT06698146 |
Colorectal Metastasis to Liver Extraction with Auxiliary Transplant and Delayed Resection |
NCT05220046 |
Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers |
NCT05058846 |
Pilot Study of Pancreatic Cancer Screening |
NCT04167969 |
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer |
NCT05703269 |
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy |
NCT04839614 |
Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia |
NCT04541381 |
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care |
NCT03854110 |
Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine |
NCT02170181 |
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation |
NCT06074510 |
PYLARIFY® PET/CT or PET/MRI in Men with Favorable Intermediate Risk (FIR) Prostate Cancer |
NCT05452681 |
Piloting Y-AMBIENT: a Quality of Life Intervention for Young African American Breast Cancer Survivors |
NCT06536881 |
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming |
NCT05366881 |
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease |
NCT04820179 |
Atezolizumab + Cabozantinib in Patients W/ Metastatic, Refractory Pancreatic Cancer |
NCT06691984 |
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer |
NCT05050084 |
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial |
NCT04986579 |
Scalp Cooling in MBC |
NCT05633979 |
Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer |
NCT05419479 |
Switch Maintenance in Pancreatic |
NCT05675579 |
A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC) |
NCT06783179 |
Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander Placement |
NCT05464810 |
Letrozole with and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer |
NCT04291612 |
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease |
NCT05259410 |
Time Restricted Eating During Chemotherapy for Breast Cancer |
NCT06818812 |
A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation |
NCT01035112 |
Magnetic Resonance Imaging of Breast Cancer |
NCT05245812 |
Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy |
NCT05563272 |
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors |
NCT04265872 |
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC |
NCT03270072 |
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients |
NCT06663072 |
Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors |
NCT05924672 |
Efficacy of Ra-223 in PSMA PET Optimally Selected Patients |
NCT05498272 |
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations |